Form 4: Andrew Toy, CEO of Clover Health, Acquires Shares Through Restricted Stock Unit Award
SEC Form 4 Filing
Clover Health CEO Andrew Toy acquired 1,910,828 shares of Class A common stock through a restricted stock unit award on October 15, 2024.
Summary
- On October 15, 2024, Andrew Toy, the CEO of Clover Health Investments, Corp., acquired 1,910,828 shares of Class A common stock.
- This acquisition was part of a time-based restricted stock unit (RSU) award.
- The RSUs will vest 25% on the first anniversary of the grant date (October 15, 2024).
- The remaining RSUs will vest in twelve equal quarterly installments starting three months after the first anniversary, contingent upon continued service.
- The RSUs will be fully vested by October 15, 2028.
- Following the transaction, Andrew Toy beneficially owns 11,713,149 shares of Class A Common Stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. It reflects standard executive compensation practices and aligns management interests with shareholders. There are no immediate negative implications.
Positives
- The RSU award aligns the CEO's interests with the long-term performance of the company.
- The vesting schedule incentivizes continued service and commitment from the CEO.
Future Outlook
The vesting schedule of the RSUs extends to October 15, 2028, indicating a long-term commitment from the CEO.
Industry Context
This type of equity compensation is common for CEOs in publicly traded companies to align their interests with shareholders and incentivize long-term growth.
Comparison to Industry Standards
- Equity compensation for CEOs varies widely based on company size, performance, and industry.
- Companies like UnitedHealth Group (UNH) and Humana (HUM) also utilize stock options and restricted stock units as part of their executive compensation packages.
- The vesting schedule of four years is a fairly standard practice to ensure long-term commitment.
Stakeholder Impact
- Shareholders may view the RSU award positively as it aligns the CEO's interests with the company's long-term success.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 10/15/2024 | Date of the transaction and initial vesting date for the RSU award. |
| 10/15/2024 | First anniversary of the grant date; 25% of RSUs vest. |
| Three months after 10/15/2025 | Start date for the remaining RSUs to vest in twelve equal quarterly installments. |
| 10/15/2028 | Date when all RSUs will be fully vested. |
| 10/17/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.